a b c d e f g h i j k l m n o p q r s t u v w x y z #

Plasma Products Lot Release Certificates

 

FANHDI 250IU A04H100341

  • Date of Issuance: 28-Jun-24

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2A006AE

  • Date of Issuance: 29-May-23

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2A007AC

  • Date of Issuance: 7-Apr-23

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2A014AG

  • Date of Issuance: 7/8/2023

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2A025AA

  • Date of Issuance: 3-Oct-23

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2A025AF

  • Date of Issuance: 26-Oct-23

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2A026AB

  • Date of Issuance: 15-Nov-23

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2B005AC

  • Date of Issuance: 17-Apr-24

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2X009AF

  • Date of Issuance: 20-Jul-22

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2X016AAA

  • Date of Issuance: 20-Sep-22

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2X016AAG (2)

  • Date of Issuance: 17-Oct-22

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2X018AL

  • Date of Issuance: 25-Nov-22

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2X023AP

  • Date of Issuance: 30-Jan-23

FEIBA (Factor VIII Inhibitor Bypassing Activity) 25U/ml Powder and solvent for solution for infusion F2X038AB

  • Date of Issuance: 22-Feb-23

FEIBA (Factor VIII Inhibitor Bypassing Activity) Powder and solvent F2V057AP

  • Date of Issuance: 16-Apr-21
<<  23 24 25 26 27 [2829 30 31 32  >>  

 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

 

 

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Khamis 18 Julai 2024, 17:26:10.
© Copyright 2018 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Menu Utama